Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes?
NBER Working Paper No. 26292
---- Acknowledgments ----
The authors thank participants of the Southern California Conference in Applied Microeconomics, Population Association of America conference, and Academy Health Annual Research Meeting for helpful comments. Tianyi Lu provided excellent research assistance. Research reported in this publication was supported by the Leonard D. Schaeffer Center for Health Policy and Economics and the National Institute on Aging of the National Institutes of Health under award 2P30AG043073. Tucker-Seeley additionally reports funding from a National Cancer Institute K01 Career Development Grant (K01 CA169041). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the National Bureau of Economic Research.
---- Disclosure of Financial Relationships for Rebecca Mary Myerson ----
Rebecca Myerson has received research funding from Bristol-Myers Squibb for investigator initiated research.
---- Disclosure of Financial Relationships for Dana Goldman ----
Goldman reports honoraria in the last two years from ACADIA Pharmaceuticals, Amgen, Aspen Institute, and Celgene Corporation; he also serves as a consultant to Precision Health Economics and hold equity (<1%) in its parent company.
---- Disclosure of Financial Relationships for Darius N. Lakdawalla ----
Dr. Lakdawalla holds equity in and serves as the Chief Strategy Officer of Precision Health Economics, which provides consulting services to firms in the pharmaceutical, biotechnology, and medical device industries. No funding or compensation was received for this particular study.